These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8737003)

  • 1. Subtypes of alcoholism and their role in therapy.
    Lesch OM; Walter H
    Alcohol Alcohol; 1996 Mar; 31 Suppl 1():63-7. PubMed ID: 8737003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subtypes of alcoholism and their role in therapy.
    Lesch OM; Walter H
    Alcohol Alcohol Suppl; 1996 Mar; 31(1):63-7. PubMed ID: 9845040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological relapse prevention of alcoholism: clinical predictors of outcome.
    Kiefer F; Helwig H; Tarnaske T; Otte C; Jahn H; Wiedemann K
    Eur Addict Res; 2005; 11(2):83-91. PubMed ID: 15785069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting the effect of naltrexone and acamprosate in alcohol-dependent patients using genetic indicators.
    Ooteman W; Naassila M; Koeter MW; Verheul R; Schippers GM; Houchi H; Daoust M; van den Brink W
    Addict Biol; 2009 Jul; 14(3):328-37. PubMed ID: 19523047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacological treatment of alcohol dependence: needs and possibilities.
    Mann K
    Alcohol Alcohol; 1996 Mar; 31 Suppl 1():55-8. PubMed ID: 8737001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acamprosate treatment in a long-term community-based alcohol rehabilitation programme.
    Poldrugo F
    Addiction; 1997 Nov; 92(11):1537-46. PubMed ID: 9519495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot study on the effects of treatment with acamprosate on craving for alcohol in alcohol-dependent patients.
    Weinstein A; Feldtkeller B; Feeney A; Lingford-Hughes A; Nutt D
    Addict Biol; 2003 Jun; 8(2):229-32. PubMed ID: 12850782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol?
    Richardson K; Baillie A; Reid S; Morley K; Teesson M; Sannibale C; Weltman M; Haber P
    Addiction; 2008 Jun; 103(6):953-9. PubMed ID: 18482418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acamprosate in the treatment of alcohol dependence: clinical and economic considerations.
    Mason BJ; Crean R
    Expert Rev Neurother; 2007 Nov; 7(11):1465-77. PubMed ID: 17997696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloninger's typology and treatment outcome in alcohol-dependent subjects during pharmacotherapy with naltrexone.
    Kiefer F; Jiménez-Arriero MA; Klein O; Diehl A; Rubio G
    Addict Biol; 2008 Mar; 13(1):124-9. PubMed ID: 17573782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acamprosate for the treatment of alcohol dependence.
    Boothby LA; Doering PL
    Clin Ther; 2005 Jun; 27(6):695-714. PubMed ID: 16117977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pragmatic trial of acamprosate in the treatment of alcohol dependence in primary care.
    Kiritzé-Topor P; Huas D; Rosenzweig C; Comte S; Paille F; Lehert P
    Alcohol Alcohol; 2004; 39(6):520-7. PubMed ID: 15304381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The European NEAT program: an integrated approach using acamprosate and psychosocial support for the prevention of relapse in alcohol-dependent patients with a statistical modeling of therapy success prediction.
    Pelc I; Ansoms C; Lehert P; Fischer F; Fuchs WJ; Landron F; Pires Preto AJ; Morgan MY
    Alcohol Clin Exp Res; 2002 Oct; 26(10):1529-38. PubMed ID: 12394286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of acamprosate on sleep during alcohol withdrawal: A double-blind placebo-controlled polysomnographic study in alcohol-dependent subjects.
    Staner L; Boeijinga P; Danel T; Gendre I; Muzet M; Landron F; Luthringer R
    Alcohol Clin Exp Res; 2006 Sep; 30(9):1492-9. PubMed ID: 16930211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of acamprosate on alcohol and food craving in patients with alcohol dependence.
    Han DH; Lyool IK; Sung YH; Lee SH; Renshaw PF
    Drug Alcohol Depend; 2008 Mar; 93(3):279-83. PubMed ID: 17983709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why is disulfiram superior to acamprosate in the routine clinical setting? A retrospective long-term study in 353 alcohol-dependent patients.
    Diehl A; Ulmer L; Mutschler J; Herre H; Krumm B; Croissant B; Mann K; Kiefer F
    Alcohol Alcohol; 2010; 45(3):271-7. PubMed ID: 20348436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary ethyl glucuronide and ethyl sulfate testing for recent drinking in alcohol-dependent outpatients treated with acamprosate or placebo.
    Dahl H; Hammarberg A; Franck J; Helander A
    Alcohol Alcohol; 2011; 46(5):553-7. PubMed ID: 21616946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic approaches to the management of alcoholism.
    Anton RF
    J Clin Psychiatry; 2001; 62 Suppl 20():11-7. PubMed ID: 11584870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of alcohol-dependent outpatients with acamprosate: a clinical review.
    Mason BJ
    J Clin Psychiatry; 2001; 62 Suppl 20():42-8. PubMed ID: 11584875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind randomized multicentre trial of acamprosate in maintaining abstinence from alcohol.
    Paille FM; Guelfi JD; Perkins AC; Royer RJ; Steru L; Parot P
    Alcohol Alcohol; 1995 Mar; 30(2):239-47. PubMed ID: 7662044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.